Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 276Thoracic 65Gastrointestinal 52Dermatologic 37Breast 35Gynecologic 34Genitourinary 27Sarcoma 10Lymphoid 7Other solid neoplasm 3CNS 3Plasma cell 1Other hematologic neoplasm 1NET 1Endocrine 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 423Precursor Cell Lymphoblastic Leukemia-Lymphoma 222Hematologic Neoplasms 212Leukemia, Lymphocytic, Chronic, B-Cell 184Myelodysplastic Syndromes 153Leukemia 121Lymphoma 86Lymphoma, Non-Hodgkin 76Multiple Myeloma 67Leukemia, Myelogenous, Chronic, BCR-ABL Positive 65Recurrence 59Leukemia, Myelomonocytic, Chronic 53Neoplasms 51Leukemia, Biphenotypic, Acute 46Burkitt Lymphoma 44Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 42Myeloproliferative Disorders 41Lymphoma, Mantle-Cell 39Lymphoma, Large B-Cell, Diffuse 38Hodgkin Disease 35Lymphoma, Follicular 32Lymphoma, B-Cell 30Waldenstrom Macroglobulinemia 25Lymphoma, B-Cell, Marginal Zone 25Leukemia, B-Cell 25Anemia, Refractory, with Excess of Blasts 21Primary Myelofibrosis 20Hematologic Diseases 20Leukemia, Myeloid, Chronic-Phase 19Myelodysplastic-Myeloproliferative Diseases 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Squamous Cell Carcinoma of Head and Neck × Other hematologic neoplasm × 90 days × Clear all
NCT06870487 2026-05-08

A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers

Pfizer

Phase 1 Terminated
6 enrolled
DermatologicHead & NeckLymphoidOther hematologic neoplasmThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Hodgkin Disease, Lung Neoplasms, Lymphoma, Non-Hodgkin, Melanoma, Neoplasm Metastasis, Neoplasms, Skin Neoplasms, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡